FIELD: biotechnology.
SUBSTANCE: invention refers to treating an individual having a disease, disorder or pathological condition of the lungs. Method comprises administering to a subject a therapeutically effective amount of placental stem cells, non-embryonic stem cells, wherein the therapeutically effective amount is an amount, sufficient to cause detectable improvement of one or more symptoms of said disease, disorder or pathological condition.
EFFECT: invention widens the range of equipment.
21 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF DISEASE, DISORDERS OR PATHOLOGICAL CONDITIONS OF LUNGS WITH APPLICATION OF PLACENTAL CELLS | 2009 |
|
RU2570550C2 |
| STROKE TREATMENT WITH APPLICATION OF ISOLATED PLACENTAL CELLS | 2009 |
|
RU2558778C2 |
| IMPROVED CELL COMPOSITION AND METHODS OF OBTAINING THEREOF | 2009 |
|
RU2563518C2 |
| IMPROVED CELL COMPOSITION AND METHODS FOR ITS PREPARATION | 2009 |
|
RU2662676C1 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTA DERIVED INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATING COMPOUNDS | 2010 |
|
RU2742171C2 |
| TUMOUR SUPPRESSION WITH APPLICATION OF INTERMEDIATE NATURAL KILLER CELLS AND IMMUNOMODULATORY COMPOUNDS OBTAINED FROM HUMAN PLACENTA | 2010 |
|
RU2642988C2 |
| AMNIOTIC ADHESIVE CELLS | 2009 |
|
RU2562154C2 |
| MESENCHYMAL STEM CELLS ORIGINATING FROM PERINATAL TISSUE: METHOD FOR THEIR PRODUCTION AND USE | 2017 |
|
RU2780179C2 |
| TUMOUR SUPPRESSION WITH USE OF HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS RECOVERED FROM HUMAN PLACENTA | 2008 |
|
RU2536242C2 |
| SUPPRESSION OF TUMORS USING HUMAN PLACENTAL PERFUSATE AND AUXILIARY NATURAL KILLER CELLS ISOLATED FROM HUMAN PLACENTA | 2008 |
|
RU2781543C2 |
